{
    "Trade/Device Name(s)": [
        "xTAG CYP2D6 Kit v3"
    ],
    "Submitter Information": "Luminex Molecular Diagnostics Inc.",
    "510(k) Number": "K093420",
    "Predicate Device Reference 510(k) Number(s)": [
        "K042259"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NTI"
    ],
    "Summary Letter Date": "August 20, 2010",
    "Summary Letter Received Date": "August 23, 2010",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21CFR862.3360"
    ],
    "Regulation Name(s)": [
        "Drug metabolizing enzyme genotyping system"
    ],
    "Analyte Class(es)": [
        "toxicology",
        "genetic molecular"
    ],
    "Analyte(s)": [
        "CYP2D6 gene variants (*1, *2, *3, *4, *5, *6, *7, *8, *9, *10, *11, *15, *17, *29, *35, *41, DUP)"
    ],
    "Specimen Type(s)": [
        "Genomic DNA",
        "Whole blood"
    ],
    "Specimen Container(s)": [
        "EDTA tube",
        "Citrate tube"
    ],
    "Instrument(s)/Platform(s)": [
        "Luminex 100/200 Instrument"
    ],
    "Method(s)/Technology(ies)": [
        "Multiplex PCR",
        "Allele-specific primer extension (ASPE)",
        "Universal Tag sorting system",
        "Fluorescent bead-based assay"
    ],
    "Methodologies": [
        "Qualitative genotyping",
        "Molecular diagnostics"
    ],
    "Submission Type(s)": [
        "Kit",
        "Assay",
        "Software"
    ],
    "Document Summary": "FDA 510(k) summary for xTAG CYP2D6 Kit v3, a multiplex qualitative genotyping assay for CYP2D6 gene variants using Luminex bead-based detection",
    "Indications for Use Summary": "Qualitative genotyping assay for simultaneous detection and identification of CYP2D6 nucleotide variants and gene rearrangements from EDTA and citrate anticoagulated whole blood, aiding clinicians in therapeutic strategy decisions for drugs metabolized by CYP2D6; not for standalone diagnostic use or prediction of drug response",
    "fda_folder": "Toxicology"
}